skip to primary navigationskip to content
 

Life sciences equity crowdfunding platform, Capital Cell shortlisted for international award

last modified Jun 23, 2017 03:38 PM
Shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017

Today, ideaSpace West members, Capital Cell, Europe’s first equity crowdfunding platform specialised in life science, has been shortlisted for the prestigious Best International Growth Business award at the UK Business Angels Association Investment Awards 2017.

Capital Cell has been trading in Spain for just over 2 years, and has successfully closed 14 life science crowdfunding campaigns, including the country’s largest life science crowdfunding campaign of over 1.2M, for a potential therapeutic cure for MS.

Scaling-up from this Spanish platform, Capital Cell UK has just launched at www.capitalcell.co.uk, with a range of companies solving unmet needs from malaria control to female fertility enhancement and autoimmune disease.

In recognition of their contribution to the European life science ecosystem, the company has now been shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017.

‘We are absolutely thrilled that Capital Cell has been recognised so early on in it’s expansion into the UK,’ says Laura Ferguson, UK Director. ‘The reception to our arrival has been overwhelmingly positive from players throughout the life science ecosystem, including specialised investors such as Angels in MedCity, with whom we are collaborating closely, as well as the NHS innovation, science parks and startup incubators. It’s wonderful to have that traction formally recognised’.

The UKBAA black-tie awards dinner will take place on July the 6th, at the Dorchester Hotel, London, with 300 leading innovators and investors assembled to celebrate the best of UK business.page1image17296page1image17456page1image17616

Capital Cell has already proven itself as a platform for early stage investment in a very challenging environment’, Chairman Ian Tomlinson adds, ‘so we are extremely excited about scaling up in the UK, which is a global leader not only in life science innovation but also in equity crowdfunding. As an investment area, life science has the potential for both huge social impact and significant financial returns and the companies listed on Capital Cell are all trying to solve a major unmet medical need. By opening up these investment opportunities to more people we hope to be able to help the UK remain at the cutting edge of life science commercialisation.'

About Capital Cell: 

Capital Cell was founded by Daniel Oliver, CEO, and has been trading in Spain for just over 2 years from their main operational office in Barcelona. Following investment into Capital Cell of more than 500k, including UK and Spanish business angels as well as “crowd” investment from their own 300kcrowdfunding campaign closed in March 2017, the company has now launched in the UK. Daniel Oliver remains in majority control of the company, with the UK launch being led alongside Laura Ferguson, UK Director.

Ian Tomlinson, UK Chairman (www.stevenagecatalyst.com/about/board_directors/ian_tomlinson/) was the co-founder of Domantis Ltd which was acquired by GSK for $454 million in 2006, and is also current Chairman of Stevenage BioScience Catalyst.

For more information, please contact:

Katie Anderton

Head of Marketing and Capital Cell

katie@capitalcell.net 

RSS Feed Latest news

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

A Breath Test Could Detect Early Cancer Signs

Jan 06, 2019

CRUK and ideaSpace City members, Owlstone Medical, have launched a new trial to discover whether it's possible to detect early stage cancer symptoms from a person's breath.

Petagene secure $2.1 Million in Funding 

Jan 03, 2019

2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

LESSONS FOR A FOUNDER: Your Fundraising Questions Answered

Dec 20, 2018

Are you going to be fundraising for your startup in 2019? The landscape of startup funding can seem bewildering. So we asked experienced fundraising coach, Jonathan Leinmuller, to share his knowledge about how best to raise capital. Here’s what he had to say...

C1209 Selected as a Startup With High Potential for International Scale

Dec 14, 2018

ideaSpace City members C1209 have been selected by Virgin as a startup with high potential for international scale, as part of the Virgin StartUp StepUp programme. This follows on from a recent feature in British Vogue which named C1209's Franklin bag as 'One of the Best Office Bags For Women'. 

View all news